Log In Get Started

News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Howard Hughes pitched as a long with a $55 entry, $45 stop, and $75 target over 180 trading days.
  • Vantage program and land monetization cited as primary upside drivers for Howard Hughes.
  • Execution risk and higher interest rates highlighted as key downside risks for the Howard Hughes trade.
  • Solid Power recommended near $2 based on a material liquidity cushion and a technical floor.
  • Upside catalyst for Solid Power is scale-up of pilot lines and partner production to trigger a re-rating.
  • Trade notes advise strict risk controls and define Solid Power as a mid-term swing with limited downside if $2 holds.

Latest Articles

ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
Sep 28, 2026
Marcus Reed
Press Releases

ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer

ALX Oncology announced the publication in Nature Medicine of positive Phase 2 clinical trial results (ASPEN-06) demonstrating that evorpacept combined with trastuzumab, ramucirumab, and paclitaxel significantly improved response rates in patients with HER2-positive gastric cancer compared to control treatments. The data revealed a 40.3% objective r…

ALXO
COMSTOCK ANNOUNCES SIGNING OF FRAMEWORK AGREEMENT FOR $1.65 BILLION STRATEGIC PARTNERSHIP WITH SOCAR
Sep 28, 2026
Sofia Navarro
Press Releases

COMSTOCK ANNOUNCES SIGNING OF FRAMEWORK AGREEMENT FOR $1.65 BILLION STRATEGIC PARTNERSHIP WITH SOCAR

Comstock Resources, Inc. announced a $1.65 billion strategic partnership agreement with Azerbaijan's SOCAR to jointly develop the Haynesville Shale natural gas assets. The agreement includes plans for SOCAR to market natural gas as LNG internationally, leveraging the assets' proximity to Gulf export facilities. The definitive purchase agreement is …

CRK
4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME
Sep 28, 2026
Jordan Park
Press Releases

4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME

4D Molecular Therapeutics (Nasdaq: FDMT) announced the initiation of the global Phase 3 4SIGHT clinical trial for its lead product candidate, 4D-150, targeting diabetic macular edema (DME), a large and underserved retinal disease market. This follows encouraging two-year results from the SPECTRA trial demonstrating safety, durable vision improvemen…

FDMT
Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD
Sep 28, 2026
Caleb Monroe
Press Releases

Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD

Keros Therapeutics, a clinical-stage biopharmaceutical company, announced dosing of the first patient in its Phase 2 trial evaluating rinvatercept in patients with Duchenne muscular dystrophy (DMD). The trial aims to assess safety, tolerability, and functional improvements in late-ambulatory and early non-ambulatory DMD patients, signaling progress…

KROS
Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer
Sep 28, 2026
Sofia Navarro
Press Releases

Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer

Lantheus Holdings has initiated dosing in the SPARROW Phase 2/3 registrational trial for LNTH-2401, a gallium-68-labelled PET imaging agent targeting the GRPR biomarker in prostate cancer. This trial aims to assess the sensitivity and specificity of LNTH-2401 PET/CT imaging compared to histopathology in approximately 400 patients, potentially expan…

LNTH
Winnebago Industries Names Simone Silva Vice President to Lead Enterprise Aftermarket and Customer Experience Strategy
Sep 28, 2026
Maya Rios
Press Releases

Winnebago Industries Names Simone Silva Vice President to Lead Enterprise Aftermarket and Customer Experience Strategy

Winnebago Industries has appointed Simone Silva as Vice President of Aftermarket and Enterprise Customer Experience, a newly created role aimed at expanding the company's aftermarket business and strengthening customer engagement across its premium outdoor recreation brands. Silva brings over 20 years of customer service leadership, with previous r…

WGO
Maris-Tech Receives Record US$10 Million Order - Its Largest-Ever Contract - for Advanced Video Systems on Next-Generation Airborne Defense Platforms
Sep 28, 2026
Marcus Reed
Press Releases

Maris-Tech Receives Record US$10 Million Order - Its Largest-Ever Contract - for Advanced Video Systems on Next-Generation Airborne Defense Platforms

Maris-Tech Ltd., a Nasdaq-listed company specializing in AI-powered edge video solutions for defense, received its largest-ever $10 million order to supply advanced video systems for multiple next-generation manned airborne platforms. The order, part of a multi-year project with Magam Safety Ltd., has potential additional purchase options that coul…

MTEK
NaaS Technology Inc.'s Parent Company Named to 2026 China Top 500 Private Enterprises List, Recognized for AI-Driven Energy Digitalization
Sep 28, 2026
Avery Klein
Press Releases

NaaS Technology Inc.'s Parent Company Named to 2026 China Top 500 Private Enterprises List, Recognized for AI-Driven Energy Digitalization

Shandong Energy Chain Holding Co., Ltd., a subsidiary of Newlinks Technology Limited and parent company of NaaS Technology Inc. (Nasdaq: NAAS), was ranked No. 401 on the 2026 China Top 500 Private Enterprises list. This recognition highlights Newlinks' leadership in advancing energy digitalization and AI integration in China's energy sector. NaaS, …

NAAS
SCYNEXIS Awarded BARDA Contract Providing Up to $214 Million in Non-Dilutive Funding for the Development of SCY-247
Sep 28, 2026
Priya Menon
Press Releases

SCYNEXIS Awarded BARDA Contract Providing Up to $214 Million in Non-Dilutive Funding for the Development of SCY-247

SCYNEXIS, Inc. announced a significant contract award from the U.S. government's BARDA, potentially providing up to $214 million in non-dilutive funding to advance SCY-247, its second-generation antifungal drug candidate, through critical development stages including Phase 2 trials and NDA submission. This funding strengthens the company’s pipeline…

SCYX
Fusemachines Accelerates AI Twin Development Through Access to IBM Fusion Infrastructure Provided by IBM Platinum Partner modulAIre
Sep 28, 2026
Nina Shah
Press Releases

Fusemachines Accelerates AI Twin Development Through Access to IBM Fusion Infrastructure Provided by IBM Platinum Partner modulAIre

Fusemachines Inc. announced enhanced access to modulAIre's IBM Fusion AI-optimized infrastructure at a nominal cost, accelerating the development of its AI Twin technology. This expanded infrastructure enables faster experimentation and refinement of complex AI models, supporting Fusemachines' goal to advance intelligent digital representations for…

FUSE
Valley National Bancorp to Acquire Bluevine Inc., Accelerating Its Digital Small Business Growth Strategy and Meaningfully Enhancing Its Core Funding Capabilities
Sep 28, 2026
Caleb Monroe
Press Releases

Valley National Bancorp to Acquire Bluevine Inc., Accelerating Its Digital Small Business Growth Strategy and Meaningfully Enhancing Its Core Funding Capabilities

Valley National Bancorp announced an agreement to acquire Bluevine Inc., a leading digital banking platform for small businesses. The acquisition aligns with Valley's strategy to enhance its core funding, expand its small business franchise, and accelerate its digital and AI capabilities. Bluevine brings $2.1 billion in low-cost digital deposits, a…

VLY
Immuneering Presents Data at 2026 AACR Conference on Pancreatic Cancer Supporting Atebimetinib’s Mechanisms Designed to Extend Survival in Pancreatic Cancer
Sep 28, 2026
Caleb Monroe
Press Releases

Immuneering Presents Data at 2026 AACR Conference on Pancreatic Cancer Supporting Atebimetinib’s Mechanisms Designed to Extend Survival in Pancreatic Cancer

Immuneering Corporation presented compelling Phase 2a clinical data at the 2026 AACR Conference demonstrating that their drug atebimetinib, combined with chemotherapy, may extend survival in pancreatic cancer patients by reducing tumor volume and preserving body mass. Patients maintaining or gaining weight had significantly longer overall survival,…

IMRX
U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
Sep 28, 2026
Priya Menon
Press Releases

U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

Palvella Therapeutics announced it received a third year of FDA grant funding to support Phase 3 trials of QTORIN™ rapamycin for microcystic lymphatic malformations, a rare disease affecting over 30,000 patients. Following positive Phase 3 SELVA trial results, the company completed its New Drug Application submission and is preparing for a potentia…

PVLA
Quantum Cyber Files Audited and Reviewed Financial Statements and Pro Forma Financial Information for Bridgeport Manufacturing Acquisition
Sep 28, 2026
Hana Yamamoto
Press Releases

Quantum Cyber Files Audited and Reviewed Financial Statements and Pro Forma Financial Information for Bridgeport Manufacturing Acquisition

Quantum Cyber N.V. (Nasdaq: QUCY) has filed audited historical financial statements and pro forma financial information related to its acquisition of Bridgeport, Connecticut manufacturing facility and operating business of Arcade Technology LLC and Arcade Realty LLC. The acquisition was completed entirely with cash and no debt was assumed. The acqu…

QUCY
CervoMed Announces Pharmacokinetic Results with New Neflamapimod Oral Tablet Formulation and Secures FDA Removal of Drug Exposure Limit
Sep 28, 2026
Maya Rios
Press Releases

CervoMed Announces Pharmacokinetic Results with New Neflamapimod Oral Tablet Formulation and Secures FDA Removal of Drug Exposure Limit

CervoMed announces a new 50 mg oral tablet formulation of neflamapimod with improved pharmacokinetics suitable for twice-daily dosing, following FDA removal of a previous plasma drug exposure limit. The company plans to advance a 100 mg twice-daily regimen expected to yield higher trough plasma concentrations linked to clinical activity. Manufactur…

CRVO